DocGo Inc. leaders are responsible for the health transportation company’s mishandling of a New York City contract and its CEO’s resume embellishment, and some must return insider profits, an investor alleges.
Five of the officers and directors sold DocGo stock for more than $4 million while possessing material nonpublic information about its prospects and then-CEO Anthony Capone’s educational background, Jung Jae Hyung says on behalf of the company. Hyung filed his derivative suit Tuesday in the US District Court for the Southern District of New York.
The company’s leadership also caused the company to repurchase its own shares at artificially ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.